Literature DB >> 10828961

Spectroscopic analysis of pH-induced changes in the molecular features of type A botulinum neurotoxin light chain.

L Li1, B R Singh.   

Abstract

Clostridial botulinum neurotoxins (BoNTs) cause neuroparalysis by blocking neurotransmitter release at the neuromuscular junctions. While the toxin's heavy chain (HC) is involved in binding and internalization, the light chain (LC) acts as a unique Zn(2+)-endopeptidase against a target protein in the exocytotic docking/fusion machinery. During the translocation of the LC to the cytosol, it is exposed to the endosomal low pH. Low pH showed a dramatic change in the BoNT/A LC polypeptide folding as indicated by differential heat denaturation. Furthermore, binding of 1-anilinonaphthalenesulfonate (ANS) revealed exposure of hydrophobic domains of BoNT/A LC at low pH. Low-pH-induced structural (and by implication the endopeptidase activity) changes were completely reversible. Exposure of BoNT/A LC to low pH (4.7) did not, however, evoke the loss of Zn(2+) bound to its active site. Implications of these observations to the delivery of active BoNT/A LC to the nerve cell are discussed. We further analyzed the nature of low-pH-induced change in the polypeptide folding of BoNT/A LC by Trp fluorescence measurements. The Trp fluorescence peak was observed at 322 nm, and the two fluorescence lifetime components estimated at 2.1 ns (88%) and 0.6 ns (12%) did not change much at low pH. These observations suggested that the two Trp residues are buried and constrained in a hydrophobic environment, and it is likely that the core of the BoNT/A LC protein matrix does not participate in the low-pH-induced structural alteration. This conclusion was further supported by the near-UV circular dichroism spectra under two pH conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828961     DOI: 10.1021/bi992729u

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

Review 1.  Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting.

Authors:  B R Singh
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

2.  Botulinum neurotoxin light chain refolds at endosomal pH for its translocation.

Authors:  Shuowei Cai; Roshan Kukreja; Sue Shoesmith; Tzuu-Wang Chang; Bal Ram Singh
Journal:  Protein J       Date:  2006-12       Impact factor: 2.371

3.  Inhibition of botulinum neurotoxin a toxic action in vivo by synthetic synaptosome- and blocking antibody-binding regions.

Authors:  M Zouhair Atassi; Behzod Z Dolimbek; Lance E Steward; K Roger Aoki
Journal:  Protein J       Date:  2010-07       Impact factor: 2.371

4.  A Heterologous Reporter Defines the Role of the Tetanus Toxin Interchain Disulfide in Light-Chain Translocation.

Authors:  Madison Zuverink; Chen Chen; Amanda Przedpelski; Faith C Blum; Joseph T Barbieri
Journal:  Infect Immun       Date:  2015-04-20       Impact factor: 3.441

5.  Structural and functional analysis of botulinum neurotoxin subunits for pH-dependent membrane channel formation and translocation.

Authors:  Gowri Chellappan; Raj Kumar; Erin Santos; Dipak Goyal; Shuowei Cai; Bal Ram Singh
Journal:  Biochim Biophys Acta       Date:  2015-05-23

6.  Identification of residues surrounding the active site of type A botulinum neurotoxin important for substrate recognition and catalytic activity.

Authors:  S Ashraf Ahmed; Mark A Olson; Matthew L Ludivico; Janice Gilsdorf; Leonard A Smith
Journal:  Protein J       Date:  2008-04       Impact factor: 2.371

Review 7.  Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.

Authors:  Michael B Chancellor; Clare J Fowler; Apostolos Apostolidis; William C de Groat; Christopher P Smith; George T Somogyi; K Roger Aoki
Journal:  Nat Clin Pract Urol       Date:  2008-05-06

8.  Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.

Authors:  Shashi K Sharma; Joseph L Ferreira; Brian S Eblen; Richard C Whiting
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

9.  Comparative membrane channel size and activity of botulinum neurotoxins A and E.

Authors:  Sweta Parikh; Bal Ram Singh
Journal:  Protein J       Date:  2007-01       Impact factor: 4.000

Review 10.  Targeted secretion inhibitors-innovative protein therapeutics.

Authors:  Foster Keith; Chaddock John
Journal:  Toxins (Basel)       Date:  2010-12-03       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.